Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression changes of proteins associated with the development of preeclampsia in maternal plasma: A case‐control study

22 Mar 2016

Abstract excerpt

Defective deep placentation, involving abnormal transformation of the spiral arteries in the junctional zone of the myometrium, is known to cause significant obstetric complications, such as preeclampsia (PE), fetal growth restriction, and placental infarction leading to fetal death. Serological biomarkers to predict and diagnose PE would help antenatal care and reduce obstetric complications. To discover...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Maternal and fetal healthcare
Share to Neurological Complications and Syndromes
Share to Pregnancy and preeclampsia studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27001287
DOI: 10.1002/pmic.201500381

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression changes of proteins associated with the development of preeclampsia in maternal plasma: A case‐control studyPMID 27001287Read ↗

First-Trimester Preeclampsia-Induced Disturbance in Maternal Blood Serum Proteome: A Pilot StudySemantic proximity Read ↗

Molecular subclasses of preeclampsia characterized by a longitudinal maternal proteomics study: distinct biomarkers, disease pathways and options for preventionSemantic proximity Read ↗

Complement and coagulation cascades activation is the main pathophysiological pathway in early-onset severe preeclampsia revealed by maternal proteomicsSemantic proximity Read ↗

Late first trimester circulating microparticle proteins predict the risk of preeclampsia < 35 weeks and suggest phenotypic differences among affected cases.Semantic proximity Read ↗

Maternal plasma proteome profiling of biomarkers and pathogenic mechanisms of early-onset and late-onset preeclampsiaSemantic proximity Read ↗

Comprehensive Maternal Serum Proteomic Profiles of Preclinical and Clinical PreeclampsiaSemantic proximity Read ↗

Classification of preeclampsia according to molecular clusters with the goal of achieving personalized preventionSemantic proximity Read ↗

Molecular Advances in Preeclampsia and HELLP SyndromeSemantic proximity Read ↗

Maternal plasma proteome profiling of biomarkers and pathogenic mechanisms of early-onset and late-onset preeclampsiaSemantic proximity Read ↗

The complement system in human pregnancy and preeclampsiaSemantic proximity Read ↗

Novel proteomics biomarkers of recurrent pregnancy loss reflect the dysregulation of immune interactions at the maternal-fetal interfaceSemantic proximity Read ↗

Detergent-Insoluble Proteome Analysis Revealed Aberrantly Aggregated Proteins in Human Preeclampsia PlacentasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.